A cost-utility analysis of a rehabilitation service for people living with and beyond cancer

BMC Health Services Research

Volumn 14, Issue 1, 2014, Pages

  Round, Jeff ^a   Leurent, Baptiste ^a   Jones, Louise ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cost utility; Economics; Health economics; Living beyond cancer; Survivorship

Indexed keywords

COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HOSPICE CARE; HUMAN; MALE; MIDDLE AGED; NATIONAL HEALTH SERVICE; NEOPLASMS; QUALITY ADJUSTED LIFE YEAR; REHABILITATION NURSING; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; FEMALE; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY-ADJUSTED LIFE YEARS; REHABILITATION NURSING; STATE MEDICINE; UNITED KINGDOM;

EID: 84988662831     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-014-0558-5     Document Type: Article

References (40)

1. Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Wain G: Breast cancer survivors' supportive care needs 2-10 years after diagnosis. Support Care Cancer 2007, 15:515-523.
2. Mellon S, Northouse LL, Weiss LK: A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nurs 2006, 29:120-131.
3. Greer JA, Jackson VA, Meier DE, Temel JS: Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin 2013, 63:349-363.
4. Parikh RB, Temel JS: Early specialty palliative care. N Engl J Med 2014, 370:1075-1076.
5. Lund S, Stone PC: Predicting survival in advanced cancer. Eur J Palliat Care 2013, 20:58-61.
6. National Council for Hospice and Specialist Palliative Care Services: Fulfilling lives: Rehabilitation in Palliative Care. London: National Council for Hospice and Specialist Palliative Care Services; 2000.
7. Stevens E, Jackson S, Milligan S: Palliative Nursing in the 21st Century. UK: Blackwell; 2014.
8. Roulston A, Bickerstaff D, Haynes T, Rutherford L, Jones L: A pilot study to evaluate an outpatient service for people with advanced lung cancer. Int J Palliat Nurs 2012, 18:225-233.
9. Davies E, Higginson IJ: Systematic review of specialist palliative day-care for adults with cancer. Support Care Cancer 2005, 13:607-627.
10. Bradley SE, Frizelle D, Johnson M: Why do health professionals refer individual patients to specialist day hospice care? J Palliat Med 2011, 14:133-138.
11. de Vries K, Wells J, Plaskota M: Evaluation of an admission and discharge process for specialist palliative day hospice in the United Kingdom using case study methodology. Int J Palliat Nurs 2012, 18:275-281.
12. Douglas HR, Normand CE, Higginson IJ, Goodwin DM: A new approach to eliciting patients' preferences for palliative day care: the choice experiment method. J Pain Symptom Manage 2005, 29:435-445.
13. Goodwin DM, Higginson IJ, Myers K, Douglas HR, Normand CE: Effectiveness of palliative day care in improving pain, symptom control, and quality of life. J Pain Symptom Manage 2003, 25:202-212.
14. Douglas HR, Normand CE, Higginson IJ, Goodwin DM, Myers K: Palliative day care: what does it cost to run a centre and does attendance affect use of other services? Palliat Med 2003, 17:628-637.
15. Mosoiu D, Dumitrescu M, Connor SR: Developing a costing framework for palliative care services. J Pain Symptom Manage 2014, 48(4):719-729.
16. Jones L, FitzGerald G, Leurent B, Round J, Eades J, Davis S, Gishen F, Holman A, Hopkins K, Tookman A: Rehabilitation in advanced, progressive, recurrent cancer: a randomized controlled trial. J Pain Symptom Manage 2013, 46:315. -U163.
17. Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A: Evaluation of an instrument to assess the needs of patients with cancer. Supportive Care Review Group. Cancer 2000, 88:217-225.
18. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M: Developing and evaluating complex interventions: the new medical research council guidance. BMJ 2008, 337:a1655.
19. Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35:1095-1108.
20. National Institute for Health and Clinical Excellence: Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence; 2008.
21. Round J: Is a QALY still a QALY at the end of life? J Health Econ 2012, 31(3):521-552.
22. Morris S, Devlin N, Parkin D: Economic Analysis in Health Care. 1st edition. Chichester: John Wiley and Sons, Ltd; 2007.
23. O'Hagan A, Stevens JW: A framework for cost-effectiveness analysis from clinical trial data. Health Econ 2001, 10:303-315.
24. O'Hagan A, Stevens JW, Montmartin J: Bayesian cost-effectiveness analysis from clinical trial data. Stat Med 2001, 20:733-753.
25. Stevens JW, O'Hagan A: Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data. Int J Technol Assess Health Care 2002, 18:782-790.
26. Briggs AH: A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes. Int J Technol Assess Health Care 2001, 17:69-82.
27. Patel A, Rendu A, Moran P, Leese M, Mann A, Knapp M: A comparison of two methods of collecting economic data in primary care. Fam Pract 2005, 22:323-327.
28. Lesley C: Unit Costs of Health and Social Care. Cantebury: Personal Social Services Research Unit, University of Kent; 2011.
29. Department of Health: NHS Payment by Results 2010-11 National Tariff Information. 2010.
30. Manca A, Hawkins N, Sculpher MJ: Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005, 14:487-496.
31. Fenwick E, Byford S: A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005, 187:106-108.
32. National Institute for Health and Clinical Excellence: Appraising Life-Extending, End of Life Treatments. London: National Institute for Clinical Excellence; 2009.
33. Sculpher MJ, Claxton K, Drummond M, McCabe C: Whither trial-based economic evaluation for health care decision making? Health Econ 2006, 15:677-687.
34. Glick H, Doshi J, Sonnad S, Polsky D: Economic Evaluation in Clinical Trials. 1st edition. Oxford: Oxford University Press; 2007.
35. Thorn JC, Coast J, Cohen D, Hollingworth W, Knapp M, Noble SM, Ridyard C, Wordsworth S, Hughes D: Resource-use measurement based on patient recall: issues and challenges for economic evaluation. Appl Health Econ Health Policy 2013, 11:155-161.
36. Sleed M, Eccleston C, Beecham J, Knapp M, Jordan A: The economic impact of chronic pain in adolescence: methodological considerations and a preliminary costs-of-illness study. Pain 2005, 119:183-190.
37. Claxton K, Posnett J: An economic approach to clinical trial design and research priority-setting. Health Econ 1996, 5:513-524.
38. Edlin R, Round J, McCabe C, Sculpher M, Claxton K, Cookson R: Cost- Effectiveness Analysis and Ageism: A Review of The Theoretical Literature. 2008.
39. National Institute for Health and Clinical Excellence: Social Value Judgements: Principles for the Development of NICE Guidance. London: NICE; 2008.
40. Briggs A, Calxton K, Sculpher M: Decision Modelling for Health Economic Evaluation. 1st edition. Oxford: Oxford University Press; 2006.